Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
25.47 USD +1.56% Intraday chart for Avantor, Inc. +0.79% +11.56%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Avantor, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM
How long will this bullish phase last? Our Logo
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
Citigroup Adjusts Price Target on Avantor to $30 From $24, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Avantor to $29 From $26, Maintains Overweight Rating MT
UBS Adjusts Avantor Price Target to $29 From $25, Maintains Buy Rating MT
Barclays Adjusts Price Target on Avantor to $27 From $24, Maintains Overweight Rating MT
Baird Adjusts Price Target on Avantor to $26 From $25, Maintains Outperform Rating MT
RBC Lifts PT on Avantor to $29 From $28, Says Execution Outshines Guidance, Remains Among Best Ideas in 2024; Keeps Outperform Rating MT
Avantor, Inc. Provides Earnings Guidance for the First Quarter for the First Quarter and Full Year 2024 CI
Transcript : Avantor, Inc., Q4 2023 Earnings Call, Feb 14, 2024
Avantor's Q4 Adjusted Earnings, Net Sales Decline MT
North American Morning Briefing :Stock Futures -2- DJ
Earnings Flash (AVTR) AVANTOR AND FINANCIAL NEWS Reports Q4 Revenue $1.72B, vs. Street Est of $1.70B MT
Earnings Flash (AVTR) AVANTOR AND FINANCIAL NEWS Posts Q4 EPS $0.25, vs. Street Est of $0.22 MT
Avantor, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Avantor, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Raymond James Adjusts Avantor Price Target to $26 From $22.50, Maintains Outperform Rating MT
Transcript : Avantor, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM
North American Morning Briefing : Bond Yields Rise -2- DJ
Evercore ISI Upgrades Avantor to Outperform From In-Line, Raises Price Target to $26 From $19.50 MT
Slow start for Wall Street Our Logo
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom... Our Logo
Deutsche Bank Adjusts Avantor Price Target to $22 From $20, Maintains Hold Rating MT
BofA Securities Adjusts Price Target on Avantor to $24 From $22, Maintains Buy Rating MT
Chart Avantor, Inc.
More charts
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
25.47 USD
Average target price
27.2 USD
Spread / Average Target
+6.78%
Consensus
  1. Stock
  2. Equities
  3. Stock Avantor, Inc. - Nyse
  4. News Avantor, Inc.
  5. Avantor Unveils New Massachusetts Facility to Support Single-Use Business